Treated post-acute sequelae after COVID-19 in a German matched cohort study using routine data from 230,256 adults.

ABSTRACT:

Background

Post-acute sequelae after COVID-19 are still associated with knowledge gaps and uncertainties at the end of 2022, e.g., prevalence, pathogenesis, treatment, and long-term outcomes, and pose challenges for health providers in medical management. The aim of this study was to contribute to the understanding of the multi-faceted condition of long-/ post-COVID. It was designed to evaluate whether a prior SARS-CoV-2 infection during the first COVID-19 wave in Germany increases the rate of disease, as measured via a record of insurance data on diagnoses, symptoms, and treatment, in the subsequent 12 months compared with matched control groups without recorded SARS-CoV-2 infection.

Method

50 outcome variables at disease, symptom and treatment levels (14 main catego

SUBMITTER: Muller D 

PROVIDER: S-EPMC10911009 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature